Librax

Chlordiazepoxide and clidinium bromide, the active ingredients in Librax, are a benzodiazepine/anticholinergic combination presented as a tablet for oral use. They are employed to relieve gastrointestinal spasm and related discomfort in adult patients.

GNH USA supplies Librax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and global markets, facilitating reliable access for healthcare providers. We maintain rigorous temperature‑controlled storage and handle all necessary import documentation to meet local authority requirements.

Librax, a gastrointestinal antispasmodic, is used to manage conditions characterized by excess gut motility and ulcer‑related pain.

- Irritable bowel syndrome: reduces abdominal cramping, normalizes bowel movements, and improves quality of life in affected adults. - Peptic ulcer disease: alleviates ulcer‑associated pain, decreases gastric secretions, and supports healing when used with standard ulcer therapy. - Gastrointestinal spasm: relaxes smooth muscle to relieve acute spasm and associated discomfort in the upper and lower gastrointestinal tract.

Librax may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness - Dry mouth - Constipation - Dizziness

Serious or Rare Side Effects: - Severe hypotension - Allergic reactions such as rash or angioedema

Before prescribing Librax, clinicians should consider several safety factors. - Assess renal and hepatic function before initiating therapy: adjust dose if impairment is present. - Avoid use in patients with known hypersensitivity to benzodiazepines or anticholinergics: discontinue if reaction occurs. - Monitor for signs of dependence or abuse: limit duration as prescribed. - Caution in elderly patients: increased risk of sedation and falls. - Pregnancy and lactation: use only if benefit outweighs risk; consult obstetrician. - Store at ambient temperature: keep in original container, protect from moisture and light.

Librax can interact with other medicines, requiring careful review.

Major Interactions (Avoid): - Concurrent use with other CNS depressants (e.g., opioids, barbiturates, alcohol): may cause profound sedation or respiratory depression. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase clidinium levels, raising anticholinergic toxicity risk. - Monoamine oxidase inhibitors: may potentiate central effects of chlordiazepoxide.

Moderate Interactions (Monitor Closely): - Anticholinergic agents (e.g., antihistamines, tricyclic antidepressants): additive dry mouth and constipation. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce clidinium efficacy. - Other benzodiazepines: additive sedation.